glp 1 and fatigue GLP-1 Receptor Agonist Mechanism: Causes Management The Potential Indirect Impact of

Mechanism of Action 20.3.8

For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Marmentini, C., Branco, R

We believe our clients deserve the highest possible award or settlement and we will fight for that

Although there have been no specific trials to show cardiorenal benefit for GLP-1RA or SGLT2i when used as first-line therapy or as monotherapy or in newly diagnosed T2D, the benefit seen in the CV outcome trials has not been found to vary with the duration of diabetes, suggesting that similar benefits might be seen early in the course of disease.4 The benefits are also not dependent on the presence of metformin

It activates receptors in the pancreas for blood sugar management by regulating insulin and inhibiting glucagon release